FDA panel recommends approval for experimental leukemia treatment

Thursday, July 13, 2017 - 09:52 in Health & Medicine

The first treatment to genetically alter a patient's own cells, to fight relapsed B-cell acute lymphoblastic leukemia, is one step closer to FDA approval.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net